As the infectious diseases market expands, Pfizer, Gilead and GSK will climb to the top of the industry and emerge as the most dominant players in the space, according to data analytics and consultancy GlobalData.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,